glutamic acid has been researched along with brimonidine tartrate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brust, PF; Harpold, MM; Lovinger, DM; McCool, BA; Pin, JP; Stauderman, KA | 1 |
| Forray, MI; Fuentealba, JA; Gysling, K | 1 |
| Donello, JE; Gil, DW; Padillo, EU; Webster, ML; Wheeler, LA | 1 |
| Baldridge, WH; Baptiste, DC; Chauhan, BC; Hartwick, AT; Jollimore, CA; Kelly, ME; Tremblay, F | 1 |
| Fong, JC; Hong, SJ; Wang, HZ; Wu, KY | 1 |
| Clarke, KG; Gil, DW; Kusari, J; Padillo, E; Zhou, SX | 1 |
| Aihara, M; Araie, M; Chen, YN; Lee, KY; Nakayama, M | 1 |
| Arencibia-Albite, F; Figueroa, J; Jiménez-Rivera, CA; Schwarz, D; Vázquez-Torres, R; Velásquez-Martinez, MC; Vélez-Hernandez, ME | 1 |
| Chai, S; Ellisman, MH; Ju, WK; Kim, KY; Lee, D; Lindsey, JD; Noh, YH; Weinreb, RN | 1 |
| Cai, J; Han, Y; Li, J; Liu, W; Wang, H | 1 |
| Bruzos-Cidón, C; Llamosas, N; Torrecilla, M; Ugedo, L | 1 |
| Jung, KI; Kim, JH; Park, CK | 1 |
12 other study(ies) available for glutamic acid and brimonidine tartrate
| Article | Year |
|---|---|
Rat group I metabotropic glutamate receptors inhibit neuronal Ca2+ channels via multiple signal transduction pathways in HEK 293 cells.
Topics: Animals; Brimonidine Tartrate; Calcium Channels; Calcium Channels, N-Type; Cell Line; Female; Glutamic Acid; GTP-Binding Proteins; Humans; In Vitro Techniques; Kidney; Neurons; Pertussis Toxin; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Recombinant Proteins; Signal Transduction; Superior Cervical Ganglion; Transfection; Vasoactive Intestinal Peptide; Virulence Factors, Bordetella | 1998 |
Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis.
Topics: Adrenergic alpha-Agonists; Animals; Brain; Brimonidine Tartrate; Extracellular Space; Glutamic Acid; In Vitro Techniques; Male; Microdialysis; Morphine; Morphine Dependence; Norepinephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Substance Withdrawal Syndrome | 2000 |
alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aspartic Acid; Brimonidine Tartrate; Chromatography, Liquid; Electroretinography; Extracellular Space; Glutamic Acid; Ischemia; Male; Mass Spectrometry; Quinoxalines; Rats; Rats, Inbred BN; Retina; Retinal Ganglion Cells; Retinal Vessels; Vitreous Body; Yohimbine | 2001 |
Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Brimonidine Tartrate; Calcium; Cell Culture Techniques; Cell Survival; Dose-Response Relationship, Drug; Fura-2; Glutamic Acid; Metoprolol; N-Methylaspartate; Neuroglia; Neuroprotective Agents; Quinoxalines; Rats; Rats, Long-Evans; Retina; Retinal Ganglion Cells; Timolol | 2002 |
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured | 2003 |
Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Topics: Adrenergic alpha-Agonists; Animals; Blood Glucose; Blood-Retinal Barrier; Blotting, Western; Brimonidine Tartrate; Capillary Permeability; Diabetes Mellitus, Experimental; Glutamic Acid; Infusion Pumps; Male; Quinoxalines; Rats; Rats, Inbred BN; Rats, Long-Evans; Retina; Vascular Endothelial Growth Factor A; Vitreous Body | 2010 |
Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.
Topics: Animals; Brimonidine Tartrate; Cell Hypoxia; Cell Separation; Cell Survival; Glutamic Acid; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Quinoxalines; Rats; Rats, Wistar; Retinal Ganglion Cells | 2010 |
Presynaptic inhibition of glutamate transmission by α2 receptors in the VTA.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brimonidine Tartrate; Clonidine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acids; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Male; Mice; Neural Inhibition; Patch-Clamp Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sodium Channel Blockers; Tetrodotoxin; Ventral Tegmental Area | 2012 |
Brimonidine blocks glutamate excitotoxicity-induced oxidative stress and preserves mitochondrial transcription factor a in ischemic retinal injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; bcl-2-Associated X Protein; bcl-Associated Death Protein; Brimonidine Tartrate; DNA-Binding Proteins; Glutamic Acid; Ischemia; Mitochondrial Proteins; Oxidative Phosphorylation; Oxidative Stress; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Receptors, N-Methyl-D-Aspartate; Retina; Retinal Diseases; Retinal Ganglion Cells; Superoxide Dismutase; Transcription Factors | 2012 |
α2-adrenergic receptors in spiral ganglion neurons may mediate protective effects of brimonidine and yohimbine against glutamate and hydrogen peroxide toxicity.
Topics: Animals; Brimonidine Tartrate; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Glutamic Acid; Hydrogen Peroxide; Neuroprotective Agents; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Spiral Ganglion; Yohimbine | 2013 |
Dysfunctional inhibitory mechanisms in locus coeruleus neurons of the wistar kyoto rat.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Glutamic Acid; Inhibitory Postsynaptic Potentials; Locus Coeruleus; Male; Neurons; Patch-Clamp Techniques; Rats; Rats, Inbred WKY; Rats, Wistar; Receptors, Adrenergic, alpha-2; Synaptic Transmission | 2015 |
α2-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Biological Transport; Brimonidine Tartrate; Chronic Disease; Excitatory Amino Acid Transporter 1; Glaucoma; Glial Fibrillary Acidic Protein; Glutamic Acid; Intraocular Pressure; Male; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Glutamate | 2015 |